12-49051631-A-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_003482.4(KMT2D):c.2052T>A(p.Pro684Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000607 in 1,572,820 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00059 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00061 ( 4 hom. )
Consequence
KMT2D
NM_003482.4 synonymous
NM_003482.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.289
Publications
0 publications found
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 12-49051631-A-T is Benign according to our data. Variant chr12-49051631-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 158748.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.289 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000589 (88/149528) while in subpopulation SAS AF = 0.00403 (19/4714). AF 95% confidence interval is 0.00264. There are 0 homozygotes in GnomAd4. There are 44 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 88 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KMT2D | NM_003482.4 | c.2052T>A | p.Pro684Pro | synonymous_variant | Exon 11 of 55 | ENST00000301067.12 | NP_003473.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KMT2D | ENST00000301067.12 | c.2052T>A | p.Pro684Pro | synonymous_variant | Exon 11 of 55 | 5 | NM_003482.4 | ENSP00000301067.7 | ||
| KMT2D | ENST00000683543.2 | c.2052T>A | p.Pro684Pro | synonymous_variant | Exon 11 of 56 | ENSP00000506726.1 | ||||
| KMT2D | ENST00000685166.1 | c.2052T>A | p.Pro684Pro | synonymous_variant | Exon 10 of 54 | ENSP00000509386.1 | ||||
| KMT2D | ENST00000692637.1 | c.2052T>A | p.Pro684Pro | synonymous_variant | Exon 10 of 54 | ENSP00000509666.1 |
Frequencies
GnomAD3 genomes AF: 0.000589 AC: 88AN: 149422Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
88
AN:
149422
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000828 AC: 182AN: 219750 AF XY: 0.000860 show subpopulations
GnomAD2 exomes
AF:
AC:
182
AN:
219750
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000608 AC: 866AN: 1423292Hom.: 4 Cov.: 37 AF XY: 0.000693 AC XY: 487AN XY: 702774 show subpopulations
GnomAD4 exome
AF:
AC:
866
AN:
1423292
Hom.:
Cov.:
37
AF XY:
AC XY:
487
AN XY:
702774
show subpopulations
African (AFR)
AF:
AC:
1
AN:
32886
American (AMR)
AF:
AC:
7
AN:
42416
Ashkenazi Jewish (ASJ)
AF:
AC:
199
AN:
23306
East Asian (EAS)
AF:
AC:
0
AN:
39330
South Asian (SAS)
AF:
AC:
264
AN:
79710
European-Finnish (FIN)
AF:
AC:
1
AN:
51712
Middle Eastern (MID)
AF:
AC:
21
AN:
5582
European-Non Finnish (NFE)
AF:
AC:
309
AN:
1089734
Other (OTH)
AF:
AC:
64
AN:
58616
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
53
107
160
214
267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000589 AC: 88AN: 149528Hom.: 0 Cov.: 31 AF XY: 0.000603 AC XY: 44AN XY: 73028 show subpopulations
GnomAD4 genome
AF:
AC:
88
AN:
149528
Hom.:
Cov.:
31
AF XY:
AC XY:
44
AN XY:
73028
show subpopulations
African (AFR)
AF:
AC:
2
AN:
40284
American (AMR)
AF:
AC:
3
AN:
15080
Ashkenazi Jewish (ASJ)
AF:
AC:
31
AN:
3458
East Asian (EAS)
AF:
AC:
0
AN:
4986
South Asian (SAS)
AF:
AC:
19
AN:
4714
European-Finnish (FIN)
AF:
AC:
0
AN:
10260
Middle Eastern (MID)
AF:
AC:
4
AN:
280
European-Non Finnish (NFE)
AF:
AC:
25
AN:
67486
Other (OTH)
AF:
AC:
4
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Dec 26, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
KMT2D: BP4, BP7, BS1
not specified Benign:2
Apr 10, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Kabuki syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.